Edgestream Partners L.P. Takes $679,000 Position in ICU Medical, Inc. (NASDAQ:ICUI)

Edgestream Partners L.P. bought a new position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 4,374 shares of the medical instruments supplier's stock, valued at approximately $679,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Venturi Wealth Management LLC increased its position in shares of ICU Medical by 1,510.0% in the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 302 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in ICU Medical during the 3rd quarter worth approximately $72,000. Smartleaf Asset Management LLC grew its position in ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after acquiring an additional 567 shares in the last quarter. Coldstream Capital Management Inc. purchased a new stake in shares of ICU Medical during the third quarter valued at approximately $227,000. Finally, OLD National Bancorp IN boosted its stake in shares of ICU Medical by 22.0% in the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock valued at $227,000 after purchasing an additional 264 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 6.70% of the stock is owned by corporate insiders.

Remove Ads

ICU Medical Stock Up 2.1 %

ICU Medical stock traded up $3.01 during midday trading on Friday, hitting $143.20. The stock had a trading volume of 91,543 shares, compared to its average volume of 231,424. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The business has a fifty day moving average price of $157.61 and a 200 day moving average price of $165.08. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The stock has a market cap of $3.51 billion, a P/E ratio of -31.33 and a beta of 0.73.

Analyst Ratings Changes

ICUI has been the topic of a number of recent analyst reports. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a research note on Wednesday, December 11th. Finally, StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a research note on Monday. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.